SCAI Therapeutics, Inc.

Board.

Total 8 .

No	Title	Date
8	[Paper] Phase I Randomized Study of SCAI-005 Ophthalmic Solution: Safety, Tolerability, and Pharmacokinetics in Healthy Korean Adults	2026-10-27
7	[Paper] Comparative study on the clinical effectiveness of low-concentration cyclosporine eye drops in patients with dry eye disease	2026-10-27
6	[ ARVO 2025 Meeting Oral Presentation] Dispersed axitinib eye drops showed excellent efficacy in a non-human primate model for Wet AMD	2025-06-20
5	[Paper] Topical formulation of sodium deoxycholate for submental lipolysis	2023-08-07
4	[Paper] Novel conformation of hyaluronic acid with improved cosmetic efficacy	2022-11-28
3	[ARVO 2021 Meeting Poster] Cyclosporine A Dispersion without Surfactants Reveals its True Efficacy in Dry Eye Syndrome	2021-06-25
2	[ARVO 2021 Meeting Poster] Toward a Non-Invasive Solution of Wet AMD: Sunitinib, Pazopanib, and Axitinib Eyedrops versus Intraocular Injection of Aflibercept	2021-06-25
1	[AAO 2020 Meeting Poster] A Step Closer to a Non-Invasive Solution of Wet Age-Related Macular Degeneration: Sunitinib and Axitinib Eye-Drops Compared to Intravitreal Injection of Aflibercept	2020-11-16